McIntosh, Ph.D., Principal Investigator
||Matthew Fitzgibbon, Scientific
|Lindsay Bergan, Research
Stimmel, Program Assistant
|Nigel Clegg, Ph.D.,
Lynn Zriny, Program Manager
|Jerry Davison, Ph.D.,
Martin McIntosh, Ph.D., is a Full Member at the Fred Hutchinson Cancer Research Center (FHCRC) and Principal Investigator of the Computational Proteomics Laboratory (CPL). Dr. McIntosh has a long history of research in biomarkers and early detection of disease, especially of ovarian cancer. He is the leader of an early detection project of the FHCRC's ovarian cancer SPORE award and is one of three PIs of the NCI's proteomics initiative consortia. Dr. McIntosh is PI of the Early Detection Research Network (EDRN) biomarker development laboratory (for breast and ovarian cancer), and his laboratory leads the data integration and mining for several consortia for cancer as well as neurodegenerative disease research. His primary research focus involves discovery and evaluation of biomarkers and biomarker panels for early disease detection. He is an Associate Editor for the Journal of Proteome Research and co-Chair of the biomarker initiative for the Human Proteome Organization (HUPO). Dr. McIntosh serves in leadership positions both at the FHCRC and nationally for biomarker discovery research programs.
Matthew Fitzgibbon is a Scientific Software Engineer in the CPL and leads the informatics team for the CPL's Breast Cancer Biomarker Discovery Consortium. Prior to joining the CPL, Matt worked on microarray designs and software at the University of Washington and on sequence analysis and comparative genomics tools at Celltech R&D Inc. He has also worked on computer graphics and visualization at Thinking Machines Corp.
Abby Stimmel is a Program Assistant for CPL and the Computational Biology Program at Fred Hutchinson Cancer Research Center. She has experience with grant writing and funding research for non-profit organizations. In 2007 Abby received a B.A. in Journalism with a concentration in Criminal Justice from Gonzaga University
Sara Lynn Zriny is the CPL's Project Manager for the Biomarker Discovery Initiative and other serum proteomics biomarker discovery projects. Sara brings to the CPL her experience as a grant administrator at the University of Washington and industry experience in software development, systems integration, and procurement gained while working at SAP, Intersperse, and The Boeing Company. Sara earned an M.B.A. in Management & Policy from the University of Arizona.